RW Investment Management LLC Acquires New Shares in Artivion, Inc. (NYSE:AORT)

RW Investment Management LLC acquired a new position in shares of Artivion, Inc. (NYSE:AORT) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 8,547 shares of the company’s stock, valued at approximately $219,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. nVerses Capital LLC acquired a new stake in shares of Artivion during the second quarter worth about $28,000. GAMMA Investing LLC lifted its stake in Artivion by 38.6% in the first quarter. GAMMA Investing LLC now owns 1,814 shares of the company’s stock valued at $38,000 after buying an additional 505 shares in the last quarter. RiverPark Advisors LLC acquired a new position in shares of Artivion in the second quarter valued at approximately $55,000. Register Financial Advisors LLC bought a new stake in shares of Artivion during the first quarter worth $114,000. Finally, Allspring Global Investments Holdings LLC raised its holdings in shares of Artivion by 291.3% during the first quarter. Allspring Global Investments Holdings LLC now owns 5,580 shares of the company’s stock worth $118,000 after acquiring an additional 4,154 shares during the period. 86.37% of the stock is currently owned by institutional investors.

Artivion Trading Up 0.3 %

Shares of NYSE:AORT opened at $25.21 on Friday. The company’s 50-day moving average price is $26.03 and its two-hundred day moving average price is $23.68. Artivion, Inc. has a one year low of $12.16 and a one year high of $29.24. The company has a debt-to-equity ratio of 1.07, a current ratio of 5.63 and a quick ratio of 4.04. The stock has a market capitalization of $1.05 billion, a PE ratio of -105.04 and a beta of 1.74.

Artivion (NYSE:AORT) last released its earnings results on Thursday, August 8th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.04. Artivion had a positive return on equity of 3.81% and a negative net margin of 2.22%. The business had revenue of $98.02 million for the quarter, compared to analyst estimates of $97.70 million. On average, equities analysts forecast that Artivion, Inc. will post 0.2 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AORT has been the subject of a number of research analyst reports. Oppenheimer upped their target price on shares of Artivion from $25.00 to $30.00 and gave the stock an “outperform” rating in a research note on Friday, August 9th. Stifel Nicolaus upped their price objective on Artivion from $28.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, September 13th. Needham & Company LLC reissued a “buy” rating and issued a $30.00 target price on shares of Artivion in a research report on Friday, August 9th. Finally, Lake Street Capital upped their price target on Artivion from $28.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, July 2nd.

Insider Transactions at Artivion

In related news, SVP Jean F. Holloway sold 2,383 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $25.76, for a total value of $61,386.08. Following the completion of the transaction, the senior vice president now directly owns 165,099 shares of the company’s stock, valued at $4,252,950.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Artivion news, VP Matthew A. Getz sold 9,420 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $25.31, for a total transaction of $238,420.20. Following the transaction, the vice president now owns 34,116 shares of the company’s stock, valued at $863,475.96. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Jean F. Holloway sold 2,383 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $25.76, for a total value of $61,386.08. Following the completion of the sale, the senior vice president now owns 165,099 shares in the company, valued at approximately $4,252,950.24. The disclosure for this sale can be found here. Insiders have sold a total of 24,679 shares of company stock worth $626,518 in the last 90 days. Corporate insiders own 8.10% of the company’s stock.

About Artivion

Artivion, Inc manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo.